Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Pharmaceuticals Breadcrumb chevron Sinovac Biotech
Sinovac Biotech logo

SVA - Sinovac Biotech Reuters News

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
RiskRating
Conservative
Size
Micro Cap
Style
Market Cap £n/a
Enterprise Value £n/a
Revenue £191.1m
Position in Universe th / 6850
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions SVA Dividends
Reuters News
All News Reuters News Company Announcements
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
30th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
29th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
28th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
27th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
26th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
23rd Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
22nd Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
21st Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
20th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
19th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
16th Aug '19 News
BRIEF-Sinovac Biotech Q2 Earnings Per Share $0.11
15th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
15th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
14th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
13th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
12th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
9th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
8th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
7th Aug '19 News
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
6th Aug '19 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.